Antidiabetic Potential of Phytochemicals Found in Vernonia amygdalina

Archna Talwar,Neha Chakraborty,Manaal Zahera,Shruti Anand,Irshad Ahmad,Samra Siddiqui,Avni Nayyar,Ashanul Haque,Mohd Saeed
DOI: https://doi.org/10.1155/2024/6111603
2024-03-29
Journal of Chemistry
Abstract:Type 2 diabetes mellitus (T2DM), or "insulin-independent diabetes mellitus," is a worldwide health concern. Diabetes affects roughly 415 million individuals worldwide, with 193 million undiagnosed cases. The number of people afflicted in the following decades is predicted to double. Although various synthetic medications are currently available to treat/manage T2DM, their side effects compel researchers to seek novel treatment options. Because of their affinity for biological receptors and broad bioactivity, nature has long been a source of innovative medication. V. amygdalina is one of the numerous natural productswith antidiabetic properties. Several studies have shown that the extracts have antidiabetic effects in vitro and in vivo. This review examined the antidiabetic and pharmacokinetic characteristics of phytoconstituents found in V. amygdalina.
chemistry, multidisciplinary
What problem does this paper attempt to address?